NeuroPace, Inc. (NPCE)
NGM · Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Peers in Medical Devices
All in industry →Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
Edwards Lifesciences Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.
Recent press releases
April 2026
NeuroPace files Annual Report Summary; no specific financial data reported
***⚠️ WARNING: The source filing provided contained no text or data. Therefore, this summary is limited to describing the *type* of document you provided (an ARS) and establishing the company's background. No financial metrics, segment data, or operational updates can be reported because they were n
NeuroPace Elects Directors and Ratifies PwC Auditor at Annual Meeting
# 📜 What This Document Is 📰 This is a Proxy Statement (Form DEF 14A). Think of it as the company's official "Who's Who" book and rulebook, mailed out to all shareholders before an Annual Meeting. 📖 It doesn't contain operational financial results; instead, it details the corporate governance str
SEC filings
All filings →Insider trades
All insider trades →NeuroPace, Inc. has no reported insider trades in the last 90 days.